Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01613846 |
|---|---|
| Brief Title: | Phase III Sequential Open-label Study to Evaluate the Efficacy and Safety of Sorafenib Followed by Pazopanib Versus Pazopanib Followed by Sorafenib in the Treatment of Advanced / Metastatic Renal Cell Carcinoma (SWITCH-II) |
| First Submitted : | May 4, 2012 |
| First Submitted that Met QC Criteria : | June 6, 2012 |
| First Posted : | June 7, 2012 (Estimate) |
| Last Update Submitted that Met QC Criteria : | April 19, 2017 |
| Last Update Posted : | April 20, 2017 |